Regression of liver fibrosis in cases of chronic liver disease type C: quantitative evaluation by using computed image analysis.
暂无分享,去创建一个
Hideo Terao | Masaru Nasu | A. Nishizono | M. Nasu | K. Kashima | T. Arita | Tsuyoshi Arita | Kenji Kashima | Akira Nishizono | Makoto Arima | H. Terao | M. Arima
[1] P. Bedossa,et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C , 1997, The Lancet.
[2] J. Hoofnagle,et al. 10‐year follow‐up after interferon‐α therapy for chronic hepatitis C , 1998 .
[3] J. Ludwig,et al. The nomenclature of chronic active hepatitis: an obituary. , 1993, Gastroenterology.
[4] K. Chayama,et al. Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection. , 1997, Journal of hepatology.
[5] J. Hoofnagle,et al. Classification of chronic hepatitis: Diagnosis, grading and staging , 1994, Hepatology.
[6] S. Seki,et al. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis , 1995, The Lancet.
[7] L. Benvegnu'. Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha Hepatocellular Carcinoma Study Group. , 1998, Lancet.
[8] J. Izopet,et al. Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial. , 2001, Journal of hepatology.
[9] N. Hayashi,et al. Long-term biochemical and virological response to natural interferon-α in patients with chronic hepatitis C , 1996, Digestive Diseases and Sciences.
[10] M. Shindo,et al. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy. , 1995, Annals of internal medicine.
[11] M. Shindo,et al. The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C. , 1997, Journal of hepatology.
[12] M. Shindo,et al. Hepatic Hepatitis C Virus RNA as a Predictor of a Long-Term Response to Interferon- Therapy , 1995, Annals of Internal Medicine.
[13] P. Marcellin,et al. Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon- Therapy , 1997, Annals of Internal Medicine.
[14] H. Asakura,et al. Interferon Inhibits Progression of Liver Fibrosis and Reduces the Risk of Hepatocarcinogenesis in Patients with Chronic Hepatitis C: A Retrospective Multicenter Analysis of 652 Patients , 2004, Digestive Diseases and Sciences.
[15] M. Kaplan,et al. Regression of Hepatic Fibrosis in Hepatitis C with Long-Term Interferon Treatment , 1998, Digestive Diseases and Sciences.
[16] J. Koskinas,et al. Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa‐2b for 6 or 12 months: A 4‐year follow‐up of 211 patients , 1997, Hepatology.
[17] M. Sata,et al. Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy , 2000, Annals of Internal Medicine.
[18] Neil Kaplowitz,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.
[19] Valeer J Desmet,et al. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435]. , 2003, Journal of hepatology.
[20] N. Hayashi,et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C , 1998, Hepatology.
[21] Y. Imai,et al. Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C , 1998, Annals of Internal Medicine.
[22] N. Hayashi,et al. Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha. , 1995, Journal of hepatology.
[23] J. Hoofnagle,et al. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. , 1998, Hepatology.